Ketamine’s rapid impact on depression linked to immune system pathways

FHS
April 15, 2024
11:18 pm

Study reveals ketamine’s potent anti-inflammatory effects on neurological disorders, showing promise for treating major depressive disorder through modulation of neuroimmune pathways.

Palliative care for cancer patients is found to be as effective given virtually as in person

CHICAGO — Comfort can be delivered to patients with advanced cancer virtually just as well as in person, according to a new study presented on Sunday

June 2, 2024

Vita 34 significantly increases earnings and operating cash flow in the first quarter – Biotech Investments

EQS-News: Vita 34 AG / Key word(s): Quarterly / Interim Statement Vita 34 significantly increases earnings and operating cash flow in the first quarter 31.05.2024

June 1, 2024

Cybin Inc. Announces Appointment of Aaron Bartlone as Chief Operating Officer | Psychedelic Invest

Cybin Inc. (NEO:CYBN / NYSE American:CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, is pleased to

June 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.